Biologic therapy for dyslipidemia

نویسندگان

چکیده

Léčba dyslipidemie představuje velmi dynamicky rostoucí segment farmakoterapie včetně výroby biologických prostředků. Ty dnes cíleně míří na různé proteiny, které se podílejí syntéze, transportu nebo metabolismu lipoproteinů. Sdělení podává přehled o současných možnostech biologické léčby dyslipidemií a léčivých prostředcích, mají potenciál rozšířit její spektrum v nejbližší době.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Combination therapy for dyslipidemia.

In the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) guidelines, the emphasis of lipid-lowering therapy is placed on reaching target plasma low-density lipoprotein cholesterol (LDL-C) levels in order to reduce the risk for coronary heart disease (CHD). Although therapeutic lifestyle changes can have a positive effect on LDL-C levels, the ATP III recognizes th...

متن کامل

Combination biologic therapy.

Biologic therapies refer to genetically engineered treatments such as monoclonal antibodies and receptor-immunoglobulin fusion proteins. Following many disappointments, the introduction of anti-tumor necrosis factor (anti-TNF alpha) therapies into the clinic has clearly demonstrated the exciting potential of biologic agents. Many of these have been designed to modulate a specific aspect of the ...

متن کامل

Biologic therapy-induced pemphigus*

An Bras Dermatol. 2017;92(4):584-95. Dear editor, Pemphigus is an autoimmune bullous disease that can affect the skin and mucous membranes, mediated by autoantibodies against desmosomal desmogleins, the main adhesion structures Marina Zoega Hayashida1 Jhonatan Rafael Siqueira Pinheiro1 Milvia Maria Simões e Silva Enokihara2 Mônica Ribeiro de Azevedo Vasconcellos1 t Biologic therapy-induced pemp...

متن کامل

Immunogenicity in biologic therapy: implications for dermatology.

It is now known that all biologic drugs, even those that are fully human, are immunogenic, that is, they have the ability to induce an immune response in the treated patient. Since the presence of antidrug antibodies may influence the levels and function of the drug in the body, this immune response can alter the efficacy of the biologic treatment and even its safety profile, depending on the m...

متن کامل

Cancer and inflammation: promise for biologic therapy.

Cancers often arise as the end stage of inflammation in adults, but not in children. As such there is a complex interplay between host immune cells during neoplastic development, with both an ability to promote cancer and limit or eliminate it, most often complicit with the host. In humans, defining inflammation and the presence of inflammatory cells within or surrounding the tumor is a critica...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Vnitr?ni? le?kar?stvi?

سال: 2021

ISSN: ['0042-773X', '1801-7592']

DOI: https://doi.org/10.36290/vnl.2021.054